NCCN Guidelines Updates: Management of Prostate Cancer

J Natl Compr Canc Netw. 2019 May 1;17(5.5):583-586. doi: 10.6004/jnccn.2019.5011.


Updates to the NCCN Guidelines for Prostate Cancer include further refinements in taking a family history, new recommendations for germline and somatic testing, use of androgen receptor blockers for nonmetastatic castration-resistant prostate cancer, advice regarding intermittent versus continuous androgen deprivation therapy, and consideration of whether to treat the primary tumor in men diagnosed with de novo metastatic prostate cancer.

Publication types

  • Letter

MeSH terms

  • Disease Management
  • Humans
  • Male
  • Practice Guidelines as Topic*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / etiology
  • Prostatic Neoplasms / therapy*